Nanoparticle radiosensitizer to be tested with whole-brain radiotherapy in new phase II trial
A new phase II trial protocol will test whether AGuIX nanoparticles, already shown to be tolerated at 100 mg/kg in ...
A new phase II trial protocol will test whether AGuIX nanoparticles, already shown to be tolerated at 100 mg/kg in ...
A case report describes a 32-year-old man whose lacrimal gland adenoid cystic carcinoma was treated with orbital exenteration and radiotherapy ...
A preclinical study reports that cardiomyocyte-targeted, ultrasound-responsive nanoparticles delivering Abelmoschus manihot extract suppressed radiation-induced ferroptosis and preserved heart function in ...
A new narrative review maps how evidence-based glioblastoma care can be delivered across resource-variable health systems in Mexico and Latin ...
Researchers have formally defined the five conditions under which comparing observed outcomes with model-predicted counterfactuals yields valid treatment effect estimates.
A four-site US chart review of 398 patients with stage IB–IIC melanoma found predominantly surgical management, with systemic therapy and ...
A Swedish multicentre randomised controlled trial protocol will test whether a structured oral health care programme improves quality of life ...
A letter in the Egyptian Journal of Neurosurgery argues that guarantee-time bias may have inflated the apparent survival benefit of ...
A brief report describes a 36-year-old man with metastatic malignant peripheral nerve sheath tumor who achieved a partial response under ...
Researchers report an immune-enhanced boron neutron capture therapy platform that achieved high intratumor boron-10 levels and a model-estimated 99.6 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine